Access all versions of the report here:
RCR21: Mavrilimumab – Version 4: May 2021
RCR21: Mavrilimumab – Version 3: April 2021
RCR21: Mavrilimumab – Version 2: March 2021
RCR21: Mavrilimumab – Version 1: January 2021